Findings of study from NCMM Group Leaders, together with collaborators at Institute for Cancer Research at Oslo University Hospital, published in Nature Communications
Director of NCMM, Professor Kjetil Taskén, has been appointed as the Head and Director of Institute for Cancer Research Oslo University Hospital (OUH)
NCMM is delighted to announce the official appointment of six new Associate Investigators and five new Young Associate Investigators
October edition of the newsletter now available
NCMM is pleased to announce that its Director, Professor Kjetil Taskén, has been formally appointed to the IMI Scientific Committee.
Research from the Morth Group shows that Zinc-binding plays an important role in the sensing and regulation of cellular pH in the human brain. Findings published in Nature Group's Scientific Reports
Jacques Dubochet, Joachim Frank and Richard Henderson awarded Nobel Prize in Chemistry 2017
Event designed to inform Norwegian researchers about the opportunities for studying, training and working at the European Molecular Biology Laboratory (EMBL).
Due to the renovation of the animal facility at UiT, Lorena Arranz, Group Leader at UiT, will be based temporarily at NCMM. She will also be joined by some members of her group.
Hosted by Finnish Nordic EMBL Partner, FIMM (Institute for Molecular Medicine Finland), the 8th annual Nordic EMBL Partnership for Molecular Medicine Meeting 2017 took place from 4-7 September in Helsinki.
The annual NLS Days conference took place on 12-14 September at the Malmö Convention Centre in Sweden.
Professor Bernt Eric Uhlin, Director of MIMS, will replace Professor Kjetil Taskén, Director of NCMM.
August edition of the NCMM monthly newsletter is now available
NCMM Associate Investigator Professor Per Lønning is joint lead-author on a recent publication that has caught the media’s attention.
June edition of the NCMM newsletter now available
NCMM seeking outstanding candidates for new Associate Investigators and Young Associate Investigators
Irep Gözen is the Lead of the Programmable Cell-like Compartments convergence environment, which was recently awarded funding by UiO: Life Science
Study published in Cell Reports shows that the accessibility of DNA varies from patient to patient, and may act as a fingerprint for prostate cancer progression.
Two papers have recently been published by NCMM’s Prostate Cancer Research Group.
NCMM Guest Researcher Professor Per Ottar Seglen presented with the prize by HM King Harald V at a special ceremony
May edition of the NCMM Newsletter now available
NCMM is delighted to welcome Professor Hartmut Luecke as the centre’s new Assistant Director.
The NCMM Annual Report is now available online.
Research groups that include NCMM Group Leader, Irep Gözen, and Director Kjetil Taskén, will receive funding as part of UiO: Life Science’s Convergence Environment programme